Jan 17, 2018 - Regulatory approvals of some key pipeline candidates along with the strong performance of products like Victoza have contributed to a rally in Novo Nordisk's (NVO) shares.
Jan 16, 2018 - Teva Pharmaceutical (TEVA) receives approval from the FDA for label expansion of its leukemia drug, Trisenox, in first-line setting.
Jan 15, 2018 - Global markets endured a volatile week, guided by opposing factors.
Jan 12, 2018 - Focus this week was on pipeline updates provided by several companies including Pfizer (PFE) at a healthcare conference while Novo Nordisk's bid to acquire Ablynx also made news.
Jan 11, 2018 - We take a look at the factors that led to the rise in Novo Nordisk's (NVO) share price in the past year.
Jan 10, 2018 - What's Lilly's next stage of growth? CEO Dave Ricks answered this question and more at the J.P. Morgan Healthcare Conference.
Jan 10, 2018 - Novo Nordisk (NVO) announced that Health Canada has approved Ozempic to improve glycemic control in adults with type II diabetes mellitus.
Jan 09, 2018 - Novo Nordisk (NVO) confirmed its revised offer made on Dec 22, to acquire Ablynx NV for $3.1 billion.
Jan 07, 2018 - These new drugs could make billions of dollars for big drugmakers. And they could make you money, too.
Jan 04, 2018 - We take a look at a few Large Cap drug stocks with a favorable combination of Zacks Rank and VGM Score. The stocks are poised to carry on their bull run this year too.